Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 4, 2026
Reporting Period: Quarter ended March 31, 2026
This filing serves as a notification that the Company issued a press release announcing its financial results for the quarter ended March 31, 2026. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the press release (Exhibit 99.1) and presentation materials (Exhibit 99.2), which are incorporated by reference but not included in the text of this 8-K summary.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Management Commentary
- Investor Communications: The Company announced participation in various meetings with investors and analysts during May and June 2026.
- Materials: Presentation materials for these meetings are furnished as Exhibit 99.2 and are available on the Company's Investor Relations website.
- Disclosure Channels: The Company utilizes its investor relations website, press releases, SEC filings, and public conference calls/webcasts to disseminate material information.
Important Facts for Investor Verification
- Verify the specific revenue and earnings figures in the press release (Exhibit 99.1) attached to this filing, as they are not listed in the 8-K text.
- Review the presentation materials (Exhibit 99.2) for updated guidance and strategic outlook discussed in May/June 2026 investor meetings.
- Note that the information in Items 2.02 and 7.01 is not deemed "filed" under Section 18 of the Exchange Act unless expressly incorporated by reference in other filings.
- Confirm the Company's status as an emerging growth company (indicated as checked in the filing) and any implications for financial reporting standards.